TY  - JOUR

T1  - Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting.

JO  - Pharmacoeconomics

PY  - 2002/01/01

AU  - Akehurst RL

AU  - Brazier JE

AU  - Mathers N

AU  - O'Keefe C

AU  - Kaltenthaler E

AU  - Morgan A

AU  - Platts M

AU  - Walters SJ

ED  - 

DO  - DOI: 10.2165/00019053-200220070-00003

VL  - 20

IS  - 7

SP  - 455

EP  - 462

Y2  - 2024/12/22

ER  -